{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:35:16Z","timestamp":1790508916360,"version":"4.1.0"},"reference-count":102,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2020,8,23]]},"DOI":"10.1080\/10428194.2020.1762883","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T14:54:06Z","timestamp":1589900046000},"page":"2313-2323","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Follicular lymphoma genomics"],"prefix":"10.1080","volume":"61","author":[{"given":"Lucy","family":"Pickard","sequence":"first","affiliation":[{"name":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palladino","sequence":"additional","affiliation":[{"name":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6021-5044","authenticated-orcid":false,"given":"Jessica","family":"Okosun","sequence":"additional","affiliation":[{"name":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.450"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01073"},{"key":"CIT0003","doi-asserted-by":"crossref","unstructured":"Seymour JF, Marcus R, Davies A, et al. Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression. Haematologica. 2019;104(6):1202\u20131208.","DOI":"10.3324\/haematol.2018.209015"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.2953.2953"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24492"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.21.7439"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1126\/science.3874430"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.10.035"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.4.1333"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V108.11.821.821"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/349254a0"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.23.11376"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-198580"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-500595"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-140616"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20606"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/S1044-579X(03)00014-2"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2856"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1038\/nature09730"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.12.027"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002197"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3943"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1038\/nature10351"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-457283"},{"key":"CIT0026","doi-asserted-by":"crossref","unstructured":"Krysiak K, Ramirez C, Gomez F, et\u00a0al. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood. 2017;129(4):473\u2013483.","DOI":"10.1182\/blood-2016-07-729954"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3940"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-733469"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0116"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1619555114"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0975"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-1417"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1501199112"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0754"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.08.006"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00975-3"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.04.011"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1038\/ng.518"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-496893"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1172\/JCI70626"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01029-x"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-500264"},{"key":"CIT0043","doi-asserted-by":"crossref","unstructured":"Yusufova NT, Soshnev A, Kloetgen A, et\u00a0al. Histone 1 mutations drive lymphomagenesis by inducing primitive stem cell functions and epigenetic instructions through profound 3D re-organization of the B-cell genome (Abstract #0023). Presented at the 62nd Annual Meeting of the American Society of Haematology, Orlando, Florida; 2019.","DOI":"10.1182\/blood-2019-127774"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23184"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy241"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-7-77"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2460"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.266"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00783.x"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.08.032"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.05.022"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1753"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.02.024"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1126\/science.1207056"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3473"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0609"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0148-6"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-019-0098-8"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1172\/JCI98288"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9969"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112744"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-194852"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1126\/science.1153629"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1038\/nature07968"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-582650"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.2192"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403844"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.074252"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.7.2562"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.209"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30090-5"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-621375"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00400"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0043-y"},{"key":"CIT0075","doi-asserted-by":"crossref","unstructured":"Haebe SS, Sathe A, et\u00a0al. Site to site comparison of follicular lymphoma biopsies by single cell RNA sequencing #297. Presented at the 62nd Annual Meeting of the American Society of Haematology, Orlando, Florida; 2019.","DOI":"10.1182\/blood-2019-129445"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0181-4"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0208"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06398.x"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-174839"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002279"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3597"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00169-2"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30102-5"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614598"},{"key":"CIT0085","doi-asserted-by":"crossref","unstructured":"Jurinovic VPV, Oestergaard MZ, et\u00a0al. Evaluation of the m7-FLIPI in patients with follicular lymphoma treated within the gallium trial: EZH2 mutation status may be a predictive marker for differential efficacy of chemotherapy #0122. Presented at the 62nd Annual Meeting of the American Society of Haematology, Orlando, Florida; 2019.","DOI":"10.1182\/blood-2019-130208"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16159"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.7"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3519"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017015164"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.5246"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1038\/nature11606"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1084"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1210371110"},{"key":"CIT0094","doi-asserted-by":"crossref","unstructured":"Morschhauser FT, Chaidos A, et\u00a0al. Phase 2 multicenter study of tazemetostat, an EZH2 inhibitor, in patients with relapsed or refractory follicular lymphoma (Abstract #123). Presented at the 62nd Annual Meeting of the American Society of Haematology, Orlando, Florida; 2019.","DOI":"10.1182\/blood-2019-128096"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1090"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.1398"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12819"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-1285"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.151738"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.4320"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017012534"},{"key":"CIT0102","doi-asserted-by":"crossref","unstructured":"Schuster SB, Assouline S, et\u00a0al. Mosunetuzumab induces complete remissions in poor prognosis non-hodgkin lymphoma patients, including those who are resistant to or relapsing after chimeric antigen receptor T-Cell (CAR-T) therapies, and is active in treatment through multiple lines (Abstract #006). Presented at the 62nd Annual Meeting of the American Society of Haematology, Orlando, Florida; 2019.","DOI":"10.1182\/blood-2019-123742"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2020.1762883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T06:46:06Z","timestamp":1666593966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2020.1762883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":102,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,8,23]]}},"alternative-id":["10.1080\/10428194.2020.1762883"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2020.1762883","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-03-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}